Rafi is the project leader for two RCN projects ( AMR-Diag and ABR-Diag) on novel diagnostics for antibiotic resistance and is the WP leader for a number of RCN, RFFI and Helse Sør Øst funded projects.
He is affiliated to Nor-OpenScreen (the Norwegian node of the EU-Openscreen infrastructure project) via an MoU with Prof. Kjetil Tasken, Biotechnology Centre, University of Oslo/Oslo University Hospital (OUS).
He is also part of the TTA - Turning the Tide of Antimicrobial resistance consortium ( https://www.ous-research.no/amr/ ), which is lead by the Oslo University Hospital.
1996 - 2000 Bachelor of Pharmacy, Jamia Hamdard, Delhi, India
2000 - 2001 Master of Science in Bioinformatics, University of Exeter, UK
2004 - 2008 PhD Bioinformatics & Drug Discovery, University of Tromsø, Norway
2018 - Till Date Associate Professor, The Artic University of Tromsø (50 % positionfrom Oct-2018)
2017 - Expert reviewer for EU H2020 grant applications
2016 - Till Date Associate Professor, Inland Norway University of Applied Sciences, Hamar, Norway (70% from Oct-2018)
2013 - 2015 Leader New Molecule Profiling, Open Innovation, AstraZeneca, Molndal, Sweden
2011 - 2013 Senior Research Scientist, Medivir AB, Stockholm, Sweden
2012 - 2013 Project Leader, Antibiotic Resistance, Medivir AB, Stockholm, Sweden
2008 - 2011 Post Doc Drug Discovery and Design, Norwegian Structural Biology Centre, University of Tromsø, Norway
2002 - 2004 Research Scientist, Team Leader, Accerlys Inc., Banglore, India
2018 - 2021
Master (M. Sc 1 year project) - Past (2016 onwards)
Lana Kragulj, Narayan Prasad Koirala, Prabin Bhandari, Elizabeth, Valentina Krivenjeva, Ewelina Rojek, Mithlesh Kumar Ray
Rafi in Media
- Antibiotic Resistance
- Big Data Analysis
- Drug Discovery
- Next Generation Sequecing